Literature DB >> 27795346

A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants.

Vasiliy P Mishin1, Tatiana Baranovich1,2, Rebecca Garten1, Anton Chesnokov1,3, Anwar I Abd Elal1,3, Michelle Adamczyk1,3, Jennifer LaPlante4, Kirsten St George4, Alicia M Fry1, John Barnes1, Stephanie C Chester5, Xiyan Xu1, Jacqueline M Katz1, David E Wentworth1, Larisa V Gubareva6.   

Abstract

The rapid evolution of influenza A(H3N2) viruses necessitates close monitoring of their antigenic properties so the emergence and spread of antigenic drift variants can be rapidly identified. Changes in hemagglutinin (HA) acquired by contemporary A(H3N2) viruses hinder antigenic characterization by traditional methods, thus complicating vaccine strain selection. Sequence-based approaches have been used to infer virus antigenicity; however, they are time consuming and mid-throughput. To facilitate virological surveillance and epidemiological studies, we developed and validated a pyrosequencing approach that enables identification of six HA clades of contemporary A(H3N2) viruses. The identification scheme of viruses of the H3 clades 3C.2, 3C.2a, 3C.2b, 3C.3, 3C.3a, and 3C.3b is based on the interrogation of five single nucleotide polymorphisms (SNPs) within three neighboring HA regions, namely 412 to 431, 465 to 481, and 559 to 571. Two bioinformatics tools, IdentiFire (Qiagen) and FireComb (developed in-house), were utilized to expedite pyrosequencing data analysis. The assay's analytical sensitivity was 10 focus forming units, and respiratory specimens with threshold cycle (CT) values of <34 typically produced good quality pyrograms. When applied to 120 A(H3N2) virus isolates and 27 respiratory specimens, the assay displayed 100% agreement with clades determined by HA sequencing coupled with phylogenetics. The multi-SNP analysis described here was readily adopted by another laboratory with pyrosequencing capabilities. The implementation of this approach enhanced the findings from virological surveillance and epidemiological studies between 2013 and 2016, which examined more than 3,000 A(H3N2) viruses.
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  A(H3N2); genotyping; influenza; pyrosequencing

Mesh:

Substances:

Year:  2016        PMID: 27795346      PMCID: PMC5228225          DOI: 10.1128/JCM.01840-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates.

Authors:  A Bissielo; N Pierse; Q S Huang; M G Thompson; H Kelly; V P Mishin; N Turner
Journal:  Euro Surveill       Date:  2016

Review 2.  Fundamentals of pyrosequencing.

Authors:  Colleen T Harrington; Elaine I Lin; Matthew T Olson; James R Eshleman
Journal:  Arch Pathol Lab Med       Date:  2013-09       Impact factor: 5.534

3.  Trends in recorded influenza mortality: United States, 1900-2004.

Authors:  Peter Doshi
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

4.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

Review 5.  The evolution of Pyrosequencing® for microbiology: From genes to genomes.

Authors:  R C Novais; Y R Thorstenson
Journal:  J Microbiol Methods       Date:  2011-04-14       Impact factor: 2.363

Review 6.  Structural basis of immune recognition of influenza virus hemagglutinin.

Authors:  I A Wilson; N J Cox
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

7.  Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species.

Authors:  T Ito; Y Suzuki; L Mitnaul; A Vines; H Kida; Y Kawaoka
Journal:  Virology       Date:  1997-01-20       Impact factor: 3.616

8.  Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype.

Authors:  E Broberg; R Snacken; C Adlhoch; J Beauté; M Galinska; D Pereyaslov; C Brown; P Penttinen
Journal:  Euro Surveill       Date:  2015-01-29

9.  Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.

Authors:  D M Skowronski; C Chambers; S Sabaiduc; G De Serres; J A Dickinson; A L Winter; S J Drews; K Fonseca; H Charest; J B Gubbay; M Petric; M Krajden; T L Kwindt; C Martineau; A Eshaghi; N Bastien; Y Li
Journal:  Euro Surveill       Date:  2015-01-29

10.  Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine.

Authors:  Grace D Appiah; Lenee Blanton; Tiffany D'Mello; Krista Kniss; Sophie Smith; Desiree Mustaquim; Craig Steffens; Rosaline Dhara; Jessica Cohen; Sandra S Chaves; Joseph Bresee; Teresa Wallis; Xiyan Xu; Anwar Isa Abd Elal; Larisa Gubareva; David E Wentworth; Jacqueline Katz; Daniel Jernigan; Lynnette Brammer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-05       Impact factor: 17.586

View more
  6 in total

1.  Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.

Authors:  Yongli Xiao; Jae-Keun Park; Stephanie Williams; Mitchell Ramuta; Adriana Cervantes-Medina; Tyler Bristol; Sarah Smith; Lindsay Czajkowski; Alison Han; John C Kash; Matthew J Memoli; Jeffery K Taubenberger
Journal:  Virology       Date:  2019-06-13       Impact factor: 3.616

2.  Design and validation of a universal influenza virus enrichment probe set and its utility in deep sequence analysis of primary cloacal swab surveillance samples of wild birds.

Authors:  Yongli Xiao; Jacqueline M Nolting; Zong-Mei Sheng; Tyler Bristol; Li Qi; Andrew S Bowman; Jeffery K Taubenberger
Journal:  Virology       Date:  2018-09-10       Impact factor: 3.616

3.  Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season.

Authors:  Michael L Jackson; Jessie R Chung; Lisa A Jackson; C Hallie Phillips; Joyce Benoit; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Kempapura Murthy; Richard Zimmerman; Mary P Nowalk; Alicia M Fry; Brendan Flannery
Journal:  N Engl J Med       Date:  2017-08-10       Impact factor: 91.245

4.  The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine.

Authors:  Joshua G Petrie; Ryan E Malosh; Caroline K Cheng; Suzanne E Ohmit; Emily T Martin; Emileigh Johnson; Rachel Truscon; Maryna C Eichelberger; Larisa V Gubareva; Alicia M Fry; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

5.  Deep Sequencing of H7N9 Influenza A Viruses from 16 Infected Patients from 2013 to 2015 in Shanghai Reveals Genetic Diversity and Antigenic Drift.

Authors:  Yong-Li Xiao; Lili Ren; Xi Zhang; Jianwei Wang; Jeffery K Taubenberger; Li Qi; John C Kash; Yan Xiao; Fan Wu
Journal:  mSphere       Date:  2018-09-19       Impact factor: 4.389

6.  Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.

Authors:  Patricia A Jorquera; Vasiliy P Mishin; Anton Chesnokov; Ha T Nguyen; Brian Mann; Rebecca Garten; John Barnes; Erin Hodges; Juan De La Cruz; Xiyan Xu; Jackie Katz; David E Wentworth; Larisa V Gubareva
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.